CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 47 filers reported holding CIDARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,589 | -16.6% | 60,060 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $67,868 | -22.9% | 60,060 | -57.1% | 0.00% | 0.0% |
| Q3 2022 | $88,000 | -24.8% | 140,000 | -41.7% | 0.00% | -33.3% |
| Q2 2022 | $117,000 | -43.8% | 240,000 | -4.0% | 0.00% | -25.0% |
| Q1 2022 | $208,000 | -52.8% | 250,000 | -28.0% | 0.00% | -50.0% |
| Q4 2021 | $441,000 | +65.8% | 347,200 | +192.1% | 0.01% | +60.0% |
| Q3 2021 | $266,000 | +10.8% | 118,878 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $240,000 | -45.0% | 118,878 | -27.5% | 0.00% | -50.0% |
| Q1 2021 | $436,000 | -23.2% | 163,878 | -42.3% | 0.01% | -33.3% |
| Q4 2020 | $568,000 | +12.7% | 283,860 | +60.4% | 0.01% | 0.0% |
| Q3 2020 | $504,000 | -22.8% | 177,004 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $653,000 | +107.3% | 177,004 | +39.4% | 0.01% | +85.7% |
| Q1 2020 | $315,000 | -20.7% | 127,004 | +23.0% | 0.01% | +40.0% |
| Q4 2019 | $397,000 | +111.2% | 103,282 | +9.4% | 0.01% | +66.7% |
| Q3 2019 | $188,000 | +18.2% | 94,382 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $159,000 | -36.4% | 94,382 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $250,000 | +65.6% | 94,382 | +46.6% | 0.00% | +50.0% |
| Q4 2018 | $151,000 | -80.8% | 64,382 | -64.0% | 0.00% | -75.0% |
| Q3 2018 | $788,000 | +61.1% | 179,000 | +90.4% | 0.01% | +60.0% |
| Q2 2018 | $489,000 | +30.1% | 94,000 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $376,000 | -41.2% | 94,000 | 0.0% | 0.00% | -42.9% |
| Q4 2017 | $639,000 | +14.3% | 94,000 | +36.2% | 0.01% | +16.7% |
| Q3 2017 | $559,000 | +69.4% | 69,000 | +56.8% | 0.01% | +50.0% |
| Q2 2017 | $330,000 | +5.8% | 44,000 | +10.0% | 0.00% | 0.0% |
| Q1 2017 | $312,000 | -62.5% | 40,000 | -50.0% | 0.00% | -63.6% |
| Q4 2016 | $832,000 | -9.2% | 80,000 | 0.0% | 0.01% | -21.4% |
| Q3 2016 | $916,000 | +11.0% | 80,000 | 0.0% | 0.01% | +7.7% |
| Q2 2016 | $825,000 | – | 80,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |